Zhuhai Drug Patent Portfolio

Zhuhai owns 1 orange book drug protected by 3 US patents Given below is the list of Zhuhai's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11419842 Neutral pH compositions of Docetaxel and human serum albumin 16 May, 2036
Active
US12090134 Neutral pH compositions of docetaxel and human serum albumin 16 May, 2036
Active
US12090135 Neutral pH compositions of docetaxel and human serum albumin 16 May, 2036
Active


Zhuhai's Family Patents


Family Patents



Zhuhai Drug List

Given below is the complete list of Zhuhai's drugs and the patents protecting them.


1. Beizray

Beizray is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11419842 Neutral pH compositions of Docetaxel and human serum albumin 16 May, 2036
(11 years from now)
Active
US12090134 Neutral pH compositions of docetaxel and human serum albumin 16 May, 2036
(11 years from now)
Active
US12090135 Neutral pH compositions of docetaxel and human serum albumin 16 May, 2036
(11 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Beizray's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List